ENDONOVO THERAPEUTICS, INC. (ENDV) Free cash flow 2014–2019
ENDONOVO THERAPEUTICS, INC. (ENDV) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$2.5MFY2019 · since FY2014: -$909,296 → -$2.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2019 | -$2.5M | +11.9% |
| FY2018 | -$2.9M | — |
| FY2015 | -$1.0M | -12.5% |
| FY2014 | -$909,296 | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice